This inventor holds 2 USPTO granted patents. Top assignee: Boehringer Mannheim Gmbh. Active years: 1997-1998.
Company Filing History:
Years Active: 1997-1998
Title: Axel Heuser: Innovator in Oligonucleotide Synthesis
Introduction
Axel Heuser is a notable inventor based in Karlsruhe, Germany. He has made significant contributions to the field of oligonucleotide synthesis, particularly through his innovative patents. His work focuses on the production of nucleosides and nucleotides, which are essential components in various biotechnological applications.
Latest Patents
Axel Heuser holds 2 patents related to nucleosides and nucleoside derivatives. His latest patents detail a process for the production of oligonucleotides, specifically those where the exocyclic amino groups of the bases adenine, guanine, cytosine, 7-deazaadenine, and 7-deazaguanine carry N-phenylacetyl groups. This process involves binding a starting nucleotide to a solid carrier, followed by the stepwise synthesis of the desired oligonucleotide using activated monomeric nucleotide building blocks. The method also includes the oxidation of trivalent phosphorus to pentavalent phosphorus during synthesis, and the subsequent cleavage of the oligonucleotide from the carrier, along with the removal of 5' protecting groups.
Career Highlights
Axel Heuser is currently associated with Boehringer Mannheim GmbH, where he continues to advance his research in oligonucleotide synthesis. His work has been instrumental in enhancing the efficiency and effectiveness of oligonucleotide production, which is crucial for various applications in molecular biology and genetics.
Collaborations
Throughout his career, Axel has collaborated with esteemed colleagues such as Herbert Waldman and Herbert Von Der Eltz. These collaborations have further enriched his research and contributed to the development of innovative solutions in the field.
Conclusion
Axel Heuser's contributions to the field of oligonucleotide synthesis through his patents and collaborations highlight his role as a significant inventor. His work continues to impact the biotechnology industry positively.
